Cargando…

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease

OBJECTIVE: To determine the key inflammatory pathways that are activated in the peripheral and CNS compartments at the mild cognitive impairment (MCI) stage of Alzheimer’s disease (AD). METHODS: A cross‐sectional study of patients with clinical and biomarker characteristics consistent with MCI‐AD in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pillai, Jagan A., Maxwell, Sean, Bena, James, Bekris, Lynn M., Rao, Stephen M., Chance, Mark, Lamb, Bruce T., Leverenz, James B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649519/ https://www.ncbi.nlm.nih.gov/pubmed/31353852 http://dx.doi.org/10.1002/acn3.50827

Ejemplares similares

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2020)

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2023)

Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes
por: Pillai, Jagan A., et al.
Publicado: (2021)

TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease
por: Pillai, Jagan A., et al.
Publicado: (2021)

Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology
por: Pillai, Jagan A., et al.
Publicado: (2021)

Association of Variation in Behavioral Symptoms With Initial Cognitive Phenotype in Adults With Dementia Confirmed by Neuropathology
por: Pillai, Jagan A., et al.
Publicado: (2022)

Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease
por: Uchida, Atsuro, et al.
Publicado: (2018)

The Alzheimer's Cell Atlas (TACA): A single‐cell molecular map for translational therapeutics accelerator in Alzheimer's disease
por: Zhou, Yadi, et al.
Publicado: (2022)

The Media Coverage of Bruce Willis Reveals Unfamiliarity With Frontotemporal Degeneration
por: Hurley, Robert S, et al.
Publicado: (2023)

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discovery
por: Zhou, Yadi, et al.
Publicado: (2021)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
por: Tao, Ye, et al.
Publicado: (2020)

TREM2 deficiency eliminates TREM2(+) inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
por: Jay, Taylor R., et al.
Publicado: (2015)

Potential role of miRNA-140 in Alzheimer’s disease
por: Akhter, Rumana, et al.
Publicado: (2019)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Direction of Information Flow in Alzheimer's Disease and MCI Patients
por: Vecchio, Fabrizio, et al.
Publicado: (2011)

Longitudinal change in regional brain volumes with exposure to repetitive head impacts
por: Bernick, Charles, et al.
Publicado: (2020)

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
por: Munawara, Usma, et al.
Publicado: (2021)

Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease
por: Xu, Jielin, et al.
Publicado: (2021)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
por: Chipi, Elena, et al.
Publicado: (2019)

Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases
por: Uchida, Atsuro, et al.
Publicado: (2020)

Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging()
por: Nir, Talia M., et al.
Publicado: (2013)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

FOOD AND SUPPLEMENT COMBINATIONS TO PREVENT OR POSTPONE AGING, MCI, AND ALZHEIMER’S DISEASE
por: Pruchnicki, Alec, et al.
Publicado: (2022)

Resilience in Mild Cognitive Impairment (MCI): Examining the Level and the Associations of Resilience with Subjective Wellbeing and Negative Affect in Early and Late-Stage MCI
por: Tsormpatzoudi, Styliani Olympia, et al.
Publicado: (2023)

Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
por: Rao, Rammohan V., et al.
Publicado: (2023)

MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes
por: Bettcher, Brianne M., et al.
Publicado: (2016)

EEG oscillations during word processing predict MCI conversion to Alzheimer's disease
por: Mazaheri, Ali, et al.
Publicado: (2017)

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal
por: Vermunt, Lisa, et al.
Publicado: (2019)

Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease
por: Xu, Jielin, et al.
Publicado: (2022)

Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease Dementia (ADD): Using the “Doors and People” Tool to Differentiate between Early aMCI—Late aMCI—Mild ADD Diagnostic Groups
por: Chatzikostopoulos, Athanasios, et al.
Publicado: (2022)

Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test
por: Pozueta, Ana, et al.
Publicado: (2011)

Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification
por: Lauterbach, Edward C.
Publicado: (2016)

Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI
por: Teipel, Stefan J., et al.
Publicado: (2017)

RESTING HEART RATE MODERATES THE RELATIONSHIP BETWEEN NEUROPSYCHIATRIC SYMPTOMS, MCI, AND ALZHEIMER’S DISEASE
por: Burke, Shanna L
Publicado: (2019)

Digital Therapeutics for MCI and Alzheimer’s disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer’s Disease conference (CTAD)
por: Shuren, J., et al.
Publicado: (2022)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Microcystin mcyA and mcyE Gene Abundances Are Not Appropriate Indicators of Microcystin Concentrations in Lakes
por: Beversdorf, Lucas J., et al.
Publicado: (2015)

The Test Your Memory for Mild Cognitive Impairment (TYM-MCI)
por: Brown, Jeremy M, et al.
Publicado: (2017)

Hierarchical Interactions Model for Predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) Conversion
por: Li, Han, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_srmjij7p0pgcj6b8sohtr03i1q